OWC Pharmaceutical Research Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 7/14/2017
Contact Info
  • 30 Shacham Street
  • P.O.B. 8324
  • Petach-Tikva 4918103
  • Israel

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001431934
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2008
Employees 6 a/o Jun 30, 2017
Company Officers/Contacts
Mordechai Bignitz CEO, President
Alon Sinai COO
Yossi Dagan CFO
Yehuda Baruch Chief Scientific Officer, Director, R&D
Richard Rubin Counsel
Company Directors
Dr. Stanley Hirsch Chairman
Mordechai Bignitz Chairman
Company Notes
  • Formerly=Dynamic Applications Corp. until 1-2015
Service Providers
Accounting/Auditing Firm
Fahn Kanne & Co.
23 Menachem Begin St.
Levenstein Tower
24th floor
Tel-Aviv, 66184

Legal Counsel
Thomas J. Craft, Jr. Esq.
18096 SE Heritage Dr
Ste. 2102
Tequesta, FL, 33469
United States

Investor Relations Firm
Not Available
OWCP Security Details
Share Structure
Market Value1 $39,505,482 a/o Sep 19, 2017
Authorized Shares 500,000,000 a/o Sep 01, 2017
Outstanding Shares 146,316,600 a/o Sep 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 118,240,011 a/o Jun 30, 2017
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 128 a/o Jul 21, 2017
Short Selling Data
Short Interest 8,080 (-83.87%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security